Operating Lease, Right-of-Use Asset of ZEVRA THERAPEUTICS, INC. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ZEVRA THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,212,000, a 84% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,212,000 +$555,000 +84% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $1,337,000 +$517,000 +63% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,496,000 +$585,000 +64% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,636,000 +$550,000 +51% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $657,000 -$133,000 -17% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $820,000 +$122,000 +17% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $911,000 +$108,000 +13% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,086,000 +$188,000 +21% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $790,000 -$198,000 -20% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $698,000 -$370,000 -35% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $803,000 -$362,000 -31% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $898,000 -$192,000 -18% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $988,000 -$153,000 -13% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $1,068,000 -$118,000 -9.9% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,165,000 -$22,000 -1.9% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,090,000 -$204,000 -16% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,141,000 -$209,000 -15% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $1,186,000 -$171,000 -13% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $1,187,000 -$217,000 -15% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $1,294,000 -$157,000 -11% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $1,350,000 -$187,000 -12% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $1,357,000 -$292,000 -18% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $1,404,000 -$314,000 -18% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $1,451,000 -$334,000 -19% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $1,537,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $1,649,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $1,718,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $1,785,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.